Okayama University Medical Research Updates (OU-MRU) Vol.43

September 11, 2017

Source: Okayama University (JAPAN), Public Relations and Information Strategy
For immediate release: 11 September 2017
Okayama University research: Potential origin of cancer-associated cells revealed

(Okayama, 11 September) Researchers at Okayama University describe in Scientific Reports that cancer-associated fibroblasts — cells that play a key role in cancer progression — originate from cancer stem cells. Preventing cancer stem cells from transforming into cancer-associated fibroblast may be a promising approach towards cancer treatment.

Cancer progression is partly governed by a specialised type of cells known as cancer-associated fibroblasts (CAFs), as they have the ability to support/mediate different signalling pathways in a tumor microenvironment. However, it is still unclear that how CAFs are generated. Now, a team of researchers led by Masaharu Seno from Okayama University has provided the first evidence that CAFs may originate from cancer stem cells (CSCs) — the cells that can develop into any type of cell occurring in a given tumor. An important implication of this finding is that novel therapeutic strategies can be designed to inhibit CSC-to-CAF conversion limiting the cancer progression

Seno and colleagues first created CSC-like cells following a protocol they had established earlier: by exposing the mouse induced pluripotent stem cells (miPSCs) , a type of reprogrammed cells with embryonic–like pluripotent state which can differentiate into any type of cells, to the conditioned medium prepared from the culture of human breast cancer cell line. The resulting cells displayed typical CSC-like phenotype. These cells exhibited three essential features of CSCs. The first one is self-renewal, which is attributed to a potential to form spheres in serum-free suspension cultures. The second one is ability to form malignant tumors in vivo. And the last one is the potential of differentiation. Here in this case the phenotype of CAF is found as one of the phenotypes CSCs differentiate into. The researchers then separated fibroblast-like cells differentiating from CSC-like spheres in the presence of conditioned medium. These cells were compared with fibroblast-like cells generated directly from miPS cells. Comparative analysis revealed that CSC generated fibroblast-like cells displayed CAF-like phenotype. Therefore, Seno and co-workers concluded that the conditioned medium plays a key role in the differentiation of CSC-like spheres into CAFs.

Finally, the expression of CAF markers (proteins that are associated with the formation of CAFs) were analysed and scientists found that the CAFs have high invasive potential when compared with normal fibroblasts. Therefore, these findings by Seno and colleagues indicate that CSCs are a source of CAF-like cells in tumor microenvironment. Their model system is a valuable tool for analysing the role of CAFs derived from CSC-like cells in the tumor microenvironment and, in the words of the researchers, “inhibiting the conversion of CSCs to CAFs might have potential therapeutic implications in the future”.

Cancer-associated fibroblasts (CAFs)

Tumor microenvironment contains various types of cells, including so-called cancer-associated fibroblasts (CAFs). CAFs play an important role in various aspects of cancer progression, such as tumor growth, inflammation, drug resistance and metastasis. So far, CAFs have not been characterized very well, and their origin has remained unclear. Masaharu Seno and colleagues have now tested the hypothesis that CAFs originate from cancer stem cells (CSCs), tumor-initiating cells. The researchers’ findings show that CSCs can indeed differentiate in CAF-like cells.

Induced pluripotent stem cells (iPSCs)
Stem cells are cells that are able to differentiate into cells of a specialized phenotype. An important property of a stem cell is its potency, indicating into what types of cells the stem cell can differentiate. So-called pluripotent stem cells (PSCs) can develop into organisms, since they can differentiate into cells of any of the three different germ layers characteristic of organisms.
An induced pluripotent stem cell (iPSC) is a PSC generated by reprogramming adult non-PSCs; a procedure developed by Dr. Shinya Yamanaka and his colleagues in 2006.
Masaharu Seno and colleagues used this iPSCs and treated with conditioned medium from breast-cancer cell lines to generate CSC-like cells, which they then showed to be able to differentiate into CAF-like cells.

Neha Nair, Anna Sanchez Calle, Maram Hussein Zahra, Marta Prieto-Vila, Aung Ko Ko Oo, Laura Hurley, Arun Vaidyanath, Akimasa Seno, Junko Masuda, Yoshiaki Iwasaki, Hiromi Tanaka, Tomonari Kasai & Masaharu Seno. A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment. Scientific Reports, July 28, 2017.
DOI: 10.1038/s41598-017-07144-5

Correspondence to
Professor Masaharu Seno, Ph.D.
Department of Biotechnology, Graduate School of
Natural Science and Technology, Okayama University,
3-1-1 Tsushimanaka, Kita-ku, Okayama 700-8530, Japan
e-mail : mseno(a)okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.

Senior Research Assistant Professor Tomonari Kasai, Ph.D.
Department of Biotechnology, Graduate School of
Natural Science and Technology, Okayama University,
3-1-1 Tsushimanaka, Kita-ku, Okayama 700-8530, Japan
e-mail : t-kasai(a)okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.

Further information
Okayama University
1-1-1 Tsushima-naka , Kita-ku , Okayama 700-8530, Japan
Public Relations and Information Strategy
E-mail: www-adm (a) adm.okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.

Website: //www.okayama-u.ac.jp/index_e.html
Okayama Univ. e-Bulletin: //www.okayama-u.ac.jp/user/kouhou/ebulletin/
About Okayama University (You Tube): https://www.youtube.com/watch?v=iDL1coqPRYIOkayama University Image Movie (You Tube): https://www.youtube.com/watch?v=KU3hOIXS5kk

Okayama University Medical Research Updates (OU-MRU)Vol.1:Innovative non-invasive ‘liquid biopsy’ method to capture circulating tumor cells from blood samples for genetic testingVol.2:Ensuring a cool recovery from cardiac arrestVol.3:Organ regeneration research leaps forwardVol.4:Cardiac mechanosensitive integratorVol.5:Cell injections get to the heart of congenital defectsVol.6:Fourth key molecule identified in bone developmentVol.7:Anticancer virus solution provides an alternative to surgeryVol.8:Light-responsive dye stimulates sight in genetically blind patientsVol.9:Diabetes drug helps towards immunity against cancerVol.10:Enzyme-inhibitors treat drug-resistant epilepsyVol.11:Compound-protein combination shows promise for arthritis treatmentVol.12:Molecular features of the circadian clock system in fruit fliesVol.13:Peptide directs artificial tissue growthVol.14:Simplified boron compound may treat brain tumoursVol.15:Metamaterial absorbers for infrared inspection technologiesVol.16:Epigenetics research traces how crickets restore lost limbsVol.17:Cell research shows pathway for suppressing hepatitis B virusVol.18:Therapeutic protein targets liver diseaseVol.19:Study links signalling protein to osteoarthritisVol.20:Lack of enzyme promotes fatty liver disease in thin patientsVol.21:Combined gene transduction and light therapy targets gastric cancerVol.22:Medical supportive device for hemodialysis catheter punctureVol.23:Development of low cost oral inactivated vaccines for dysenteryVol.24:Sticky molecules to tackle obesity and diabetesVol.25:Self-administered aroma foot massage may reduce symptoms of anxietyVol.26:Protein for preventing heart failureVol.27:Keeping cells in shape to fight sepsisVol.28:Viral-based therapy for bone cancerVol.29:Photoreactive compound allows protein synthesis control with lightVol.30:Cancer stem cells’ role in tumor growth revealedVol.31:Prevention of RNA virus replicationVol.32:Enzyme target for slowing bladder cancer invasionVol.33:Attacking tumors from the insideVol.34:Novel mouse model for studying pancreatic cancerVol.35:Potential cause of Lafora disease revealedVol.36:Overloading of protein localization triggers cellular defectsVol.37:Protein dosage compensation mechanism unravelledVol.38:Bioengineered tooth restoration in a large mammalVol.39:Successful test of retinal prosthesis implanted in ratsVol.40:Antibodies prolong seizure latency in epileptic miceVol.41:Inorganic biomaterials for soft-tissue adhesionVol.42:Potential drug for treating chronic pain with few side effects